Ukr.Biochem.J. 2022; Volume 94, Issue 3, May-Jun, pp. 39-46

doi: https://doi.org/10.15407/ubj94.03.039

Correlation between adiponectin level and obesity as a risk factor for allergy disease

29.09.2022   Uncategorized   No comments

M. Spasovska1*, T. K. Panovska2

1General Hospital, Ohrid, R.Macedonia;
2Faculty of Pharmacy, Ss. Cyril and Methodius University, Skopje, R. Macedonia;
*e-mail: spasovskamilena@yahoo.com

Received: 28 November 2021; Revised: 30 June 2022;
Accepted: 29 September 2022; Available on-line: 06 October 2022

Much research has focused on the connection between two inflammatory conditions, allergic reactions and obesity which has led to a focus on adiponectin, hormone with anti-inflammatory properties secreted by adipose tissue. The aim of this study was to determine the association of adiponectin with obesity, as a risk factor for the development of allergic condition in order to rationalize approach to its treatment. Research methods for inflammatory markers and biochemical parameters involve immunoassay technique. Statistical analysis was performed with Student’s t-test, Wilcoxon T-test and coefficient of correlation. The study included apparently healthy subjects and patients with allergy conditions with confirmed presence of specific IgE, classified into 2 groups according to their body mass index (BMI). The obtained data showed negative correlation (cor = – 0.6), between adiponectin levels and BMI values. Thus, decreased level of adiponectin is associated with increased BMI. The mean values of adiponectin in the studied population, with high statistical differen­ces between the groups (19.1 ± 1.5; 17.7 ± 0.9), (18.8± 1.1; 16.6 ± 1.0) demonstrated the relationship between low adiponectin level and development of obesity, and what, in turn, increasd risk of developing allergic conditions. The assumption was made that adiponectin may be used as a sensitive biochemical marker for early diagnostics of allergic reactions.

Keywords: , , ,

References:

  1. Achari AE, Jain SK. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int J Mol Sci. 2017;18(6):1321. PubMed, PubMedCentral, CrossRef
  2. Sun Y, Xun K, Wang C, Zhao H, Bi H, Chen X, Wang Y. Adiponectin, an unlocking adipocytokine. Cardiovasc Ther. 2009;27(1):59-75. PubMed, CrossRef
  3. Luo Y, Liu M. Adiponectin: a versatile player of innate immunity. J Mol Cell Biol. 2016;8(2):120-128. PubMed, PubMedCentral, CrossRef
  4. Menzaghi C, Trischitta V. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality. Diabetes. 2018;67(1):12-22. PubMed, PubMedCentral, CrossRef
  5. Borges MC, Barros AJD, Ferreira DLS, Casas JP, Horta BL, Kivimaki M, Kumari M, Menon U, Gaunt TR, Ben-Shlomo Y, Freitas DF, Oliveira IO, Gentry-Maharaj A, Fourkala E, Lawlor DA, Hingorani AD. Metabolic Profiling of Adiponectin Levels in Adults: Mendelian Randomization Analysis. Circ Cardiovasc Genet. 2017;10(6):e001837. PubMed, PubMedCentral, CrossRef
  6. Borges MC, Lawlor DA, de Oliveira C, White J, Horta BL, Barros AJD. Role of Adiponectin in Coronary Heart Disease Risk: A Mendelian Randomization Study. Circ Res. 2016;119(3):491-499. PubMed, PubMedCentral, CrossRef
  7. Choi HM, Doss HM, Kim KS. Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases. Int J Mol Sci. 2020;21(4):1219. PubMed, PubMedCentral, CrossRef
  8. Cortes-Telles A, Ortiz-Farias DL, Pou-Aguilar YN, Almeida-de-la-Cruz L, Perez-Padilla JR. Clinical impact of obesity on respiratory diseases: A real-life study. Lung India. 2021;38(4):321-325. PubMed, PubMedCentral, CrossRef
  9. Sirjani M, Shokouhi Shoormasti R, Sabetkish N, Ayazi M, Khodayari Namini N, Tayebi B, Pourpak Z. The potential anti-inflammatory role of adiponectin in food allergy: a case-control study on children. Br J Nutr. 2018;120(10):1117-1121. PubMed, CrossRef
  10. Shin SS, Yoon M. Regulation of Obesity by Antiangiogenic Herbal Medicines. Molecules. 2020;25(19):4549. PubMed, PubMedCentral, CrossRef
  11. Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol. 2010;21(3):406-412. PubMed, PubMedCentral, CrossRef
  12. Flegal KM, Wei R, Ogden C. Weight-for-stature compared with body mass index-for-age growth charts for the United States from the Centers for Disease Control and Prevention. Am J Clin Nutr. 2002;75(4):761-766. PubMed, CrossRef
  13. Salah A, Ragab M, Mansour W, Taher M. Leptin and adiponectin are valuable serum markers explaining obesity/bronchial asthma interrelationship. Egypt J Chest Dis Tuberc. 2015;64(3):529-533. CrossRef
  14. WMA, 2013. Declaration of Helsinki-ethical principles for medical research involving human subjects, Brazil.
  15. Hosny SS, Farres MN, Melek NA, Kamal ST, EI Najjar MR, Abou EI Fotoh RH, Abd ElGward AM, Elmahdi AR. Assessment of serum od adiponectin and resistin in adult patients with asthma: relation to obesity and disease severity. Egypt J Chest Dis Tuberc. 2021;70:223-230.
  16. Furukawa S, Asano K, Kobayashi H. Suppressive Activity of Adiponectin on the Development of Allergic Rhinitis in Mice. In Vivo. 2019;33(1):93-98. PubMed, PubMedCentral CrossRef
  17. Abdul Wahab A, Maarafiya MM, Soliman A, Younes NBM, Chandra P. Serum Leptin and Adiponectin Levels in Obese and Nonobese Asthmatic School Children in relation to Asthma Control. J Allergy (Cairo). 2013;2013:654104. PubMed, PubMedCentral, CrossRef
  18. 18. Gariballa S, Alkaabi J, Yasin J, Al Essa A. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disord. 2019;19(1):55. PubMed, PubMedCentral, CrossRef
  19. Sood A, Shore SA. Adiponectin, Leptin, and Resistin in Asthma: Basic Mechanisms through Population Studies. J Allergy (Cairo). 2013;2013:785835. PubMed, PubMedCentral, CrossRef
  20. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003;26(8):2442-2450. PubMed, CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.